A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Clinical trial NCT06389877 · RECRUITING
Trial details
- NCT number
- NCT06389877
- Sponsor
- Beam Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2028-05-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.